INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

This study is the first to evaluate the efficacy and safety of adalimumab in Chinese patients with AS. Methods Chinese adults with active AS who had an inadequate response or were intolerant to ≥1 non ...